Elisa T. Helbig

3.0k total citations
7 papers, 110 citations indexed

About

Elisa T. Helbig is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Elisa T. Helbig has authored 7 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 2 papers in Neurology and 2 papers in Epidemiology. Recurrent topics in Elisa T. Helbig's work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Long-Term Effects of COVID-19 (2 papers). Elisa T. Helbig is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Long-Term Effects of COVID-19 (2 papers). Elisa T. Helbig collaborates with scholars based in Germany, Switzerland and United Kingdom. Elisa T. Helbig's co-authors include Leif Erik Sander, Florian Kurth, Martin Witzenrath, Lena J. Lippert, Norbert Suttorp, Bastian Opitz, Thomas Zöller, Christoph Ruwwe‐Glösenkamp, Charlotte Thibeault and Daniel Grund and has published in prestigious journals such as Respiratory Medicine, JCI Insight and Infection.

In The Last Decade

Elisa T. Helbig

7 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa T. Helbig Germany	5	57	49	29	29	23	7	110
Karlijn van der Straten Netherlands	6	47 0.8×	76 1.6×	6 0.2×	9 0.3×	13 0.6×	9	112
Michael J. Peluso United States	3	63 1.1×	41 0.8×	19 0.7×	7 0.2×	10 0.4×	6	93
Grace Kenny Ireland	6	41 0.7×	42 0.9×	16 0.6×	5 0.2×	10 0.4×	16	93
Sabine Koppelstätter Austria	4	49 0.9×	51 1.0×	9 0.3×	9 0.3×	10 0.4×	4	76
Blerta Kertusha Italy	6	30 0.5×	62 1.3×	14 0.5×	11 0.4×	16 0.7×	13	123
Rhonda Sin‐Ling Chee United Kingdom	4	71 1.2×	75 1.5×	10 0.3×	6 0.2×	15 0.7×	5	112
Maximilian Münchhoff Germany	3	24 0.4×	30 0.6×	11 0.4×	9 0.3×	7 0.3×	6	58
Niklas Broman Finland	3	49 0.9×	78 1.6×	10 0.3×	9 0.3×	19 0.8×	5	106
Mariana Simão Xavier Brazil	4	56 1.0×	69 1.4×	8 0.3×	2 0.1×	12 0.5×	7	108
Mario Caldararo United States	5	21 0.4×	34 0.7×	8 0.3×	11 0.4×	5 0.2×	12	73

Countries citing papers authored by Elisa T. Helbig

Since Specialization

Citations

This map shows the geographic impact of Elisa T. Helbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa T. Helbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa T. Helbig more than expected).

Fields of papers citing papers by Elisa T. Helbig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa T. Helbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa T. Helbig. The network helps show where Elisa T. Helbig may publish in the future.

Co-authorship network of co-authors of Elisa T. Helbig

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa T. Helbig. A scholar is included among the top collaborators of Elisa T. Helbig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa T. Helbig. Elisa T. Helbig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Thibeault, Charlotte, Kanika Vanshylla, Veronica Di Cristanziano, et al.. (2023). Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19. JCI Insight. 8(8). 2 indexed citations

Kurth, Florian, Elisa T. Helbig, Lena J. Lippert, et al.. (2022). Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial. Journal of Global Antimicrobial Resistance. 32. 44–47. 8 indexed citations

Lingscheid, Tilman, Lena J. Lippert, David Hillus, et al.. (2022). Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study. Infection. 50(6). 1441–1452. 7 indexed citations

Cryar, Adam, Oliver Lemke, Pinkus Tober‐Lau, et al.. (2022). A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study. EClinicalMedicine. 49. 101495–101495. 20 indexed citations

Steinbeis, Fridolin, Charlotte Thibeault, Felix Doellinger, et al.. (2021). Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months. Respiratory Medicine. 191. 106709–106709. 60 indexed citations

Helbig, Elisa T., et al.. (2017). Novel Insights in Fetal Cardiomyopathy due to in utero Herpes Simplex Virus Infection. Fetal Diagnosis and Therapy. 42(3). 236–239. 2 indexed citations

Helbig, Elisa T., Bastian Opitz, & Leif Erik Sander. (2013). Adjuvant Immunotherapies as a Novel Approach to Bacterial Infections. Immunotherapy. 5(4). 365–381. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact